Results 331 to 340 of about 1,710,556 (364)

Multiple Sclerosis: Pathogenesis, Symptoms, Diagnoses and Cell-Based Therapy

Cell journal, 2016
Multiple sclerosis (MS) is a chronic inflammatory disease characterized by central nervous system (CNS) lesions that can lead to severe physical or cognitive disability as well as neurological defects. Although the etiology and pathogenesis of MS remains
N. Ghasemi, S. Razavi, E. Nikzad
semanticscholar   +1 more source

Regulatory Oversight of Cell- and Tissue-Based Therapeutic Products and Gene Therapy Products in Singapore

2015
The regulatory environment for cell- and tissue-based therapeutic products and gene therapy products is rapidly evolving and drug regulatory agencies are working towards establishing a risk-based system in the regulatory framework. Similarly in Singapore, a risk-based tiered approach has been applied whereby clinical trials and product licence of high ...
Choon Wee, Goh, Srinivasan N, Kellathur, Lee Lee, Ong, Xiaofeng, Wu   +3 more
openaire   +2 more sources

Regulatory Framework for Cell and Tissue Based Therapies in Europe

2016
Whereas some basic therapies based on tissues and cells have been in clinical use for years, advances in regenerative medicine present new challenges and new types of products for regulation. This article focuses on cell therapies which can be classified as medicinal products across the European Union.
Gudrun Tiedemann, Sebastian Sethe
openaire   +1 more source

Regulatory Frameworks for Cell and Tissue Based Therapies in Europe and the USA

2010
Whereas some basic therapies based on tissues and cells have been in clinical use for years, regulatory regimes applying to such applications have recently been revised and extended in Europe and in the US. Moreover, advances in regenerative medicine present new challenges and new types of products for regulation.
Gudrun Tiedemann, Sebastian Sethe
openaire   +1 more source

Tissue-based Gene Expression Diagnosis of Mild and Moderate T-cell-mediated Rejection to Guide Therapy in Kidney Transplants

Transplantation
Background. Mild histologic lesions of tubulo-interstitial inflammation could represent a “response-to-wounding” rather than allorecognition. Tissue gene expression may complement histopathology for T-cell-mediated rejection (TCMR) diagnostics. Methods.
Dhiren, Kumar, Nihar, Raju, Bekir, Tanriover, Louiza, Azzouz, Irfan, Moinuddin, Mary, Philogene, Layla, Kamal, Felecia, McDougan, Hugh Davis, Massey, Selvaraj, Muthusamy, Inkoo, Lee, Philip, Halloran, Gaurav, Gupta   +12 more
openaire   +2 more sources

Ischemic preconditioning for cell-based therapy and tissue engineering.

Pharmacology and Therapeutics, 2014
S. Hsiao, R. Dilley, G. Dusting, Shiang Y. Lim   +3 more
semanticscholar   +1 more source

Cell- and tissue-based therapies for lung disease

2020
Jeffrey A. Whitsett, William Zacharias, Daniel Swarr, Vladimir V. Kalinichenko   +3 more
openaire   +1 more source

Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions

Ca-A Cancer Journal for Clinicians, 2023
Balazs Dome
exaly  

Advanced therapies in wound management: cell and tissue based therapies, physical and bio-physical therapies smart and IT based technologies

Journal of Wound Care, 2018
Piaggesi, Alberto, Låuchli, Severin, Bassetto, Franco, Biedermann, Thomas, Marques, Alexandra, Najafi, Bijan, Palla, Ilaria, Scarpa, Carlotta, Seimetz, Diane, Triulzi, Isotta, Turchetti, Giuseppe, Vaggelas, Annegret   +11 more
openaire   +3 more sources

〈1046〉 Cell-Based Advanced Therapies and Tissue-Based Products

2021
openaire   +1 more source